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Resonances for lactate are broadened in 500 MHz ‘H NMR spectra of human blood plasma nd only about one-third 
is visible in Hahn spin-echo spectra. Similar effects are observed for some other carboxylate anions. Lactate added to 
the high-M, fraction of plasma can give rise to peaks which are too broad to observe in either single-pulse or spin-echo 
spectra. Addition of agents such as NH,CI of SDS dramatically increases the intensities of lactate peaks. Some glyco- 
proteins appear to broaden lactate resonances. 
‘H-NMR; Lactate; Blood plasma; Glycoprotein; (Human) 
1. INTRODUCTION 
Proton NMR spectra of blood plasma are very However, it seems unlikely that high-resolution 
complicated even at high frequency (e.g. ‘H NMR spectra of plasma will be of routine 
500 MHz). They contain many overlapping broad clinical use until the factors which affect the inten- 
resonances arising largely from proteins and sities and linewidths of resonances are better 
lipoprotein particles, and sharper resonances from understood. Because plasma is a heterogeneous 
small molecules and highly mobile regions of mixture of lipoprotein particles, proteins, small 
macromolecules. Despite this, some specific molecules and ions there are a large number of 
assignments can be made, especially with the aid of possibilities for molecular interactions. The bin- 
spin-echo methods which, in effect, act as ‘mobili- ding of small molecules to proteins, for example, 
ty filters’, allowing only peaks from protons with can lead to severe broadening of resonances 
long TZ values to appear in the spectrum [l-5]. [12,13]. 
There have already been suggestions that ‘H 
NMR spectra of plasma will be of diagnostic 
clinical value. For example, resonances for ketone 
bodies have been correlated with the control of 
diabetes mellitus by insulin, those for lipids with 
hyperlipidaemia [2], peaks for lactate [6], 
fucosylated lipids [7] and lipoproteins [8] with 
malignant cancer, and resonances for other small 
molecules with inherited metabolic disorders [9], 
We report here that resonances for lactate, and 
some other small organic anions, are often 
specifically broadened in ‘H NMR spectra of 
blood plasma, and the intensities of their Hahn 
spin-echo peaks greatly reduced. In effect, there is 
a pool of ‘NMR-invisible’ lactate, which makes 
quantitation difficult. We show that such effects 
can be observed when lactate is added to the high- 
A4, fraction of plasma and that, in some cir- 
cumstances lactate resonances are too broad to 
detect in either single-pulse or Hahn spin-echo 
spectra. We have discovered that a variety of 
agents can increase the intensity of these 
resonances, and the possible involvement of 
glycoproteins in anion binding is considered. 
Correspondence address: P.J. Sadler, Department of 
Chemistry, Birkbeck College, University of London, Gordon 
House, 29 Gordon Square, London WClE 6BT, England 
organ damage through drug overdose [lo], and the 
efficiency of haemodialysis [ 111. 
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Our observations not only have implications for 
the use of ‘H NMR in clinical measurements and 
in other in vivo ‘H NMR experiments [ 141, but also 
raise wider questions about the role of organic 
anions in controlling protein function and that of 
proteins in controlling anion transport and 
delivery. 
2. EXPERIMENTAL 
2.1. Blood plasma 
Venous blood from healthy consenting volunteers was drawn 
and placed in standard clinical vials containing anticoagulant. 
It was centrifuged and the plasma was either used fresh, or 
stored at - 20°C and thawed at room temperature immediately 
before use. A plasma sample from a ketoacidotic subject was 
kindly supplied by Dr A.F. Macleod (St Thomas’ Hospital). 
Low-molecular-mass plasma ultrafiltrates were obtained us- 
ing Amicon centricon devices (10 kDa cut-off) washed with 
MeOH followed by HzO. High-molecular-mass fractions were 
obtained by dialysis in washed cellulose sacks (Sigma, 10 kDa 
cut-off) at 4°C over -12 h with frequent changes (3-4) of ex- 
ternal medium (Hz0 or 0.15 M NaCl, - 1 l/ml plasma). Sodium 
bicarbonate (26 mM) was added to some samples (e.g. that for 
fig.2) before dialysis to enhance lactate displacement. When 
freeze-dried, samples were made up to their original volume 
with D20. Proteins were also removed from whole blood and 
plasma by HC104 precipitation (1 :2, v/v; 8% ice-cold HC104, 
shaken vigorously, centrifuged and neutralized with KOH). 
2.2. NMR spectroscopy 
500 MHz ‘H NMR spectra were recorded on a Bruker 
AM500 spectrometer (MRC Biomedical NMR Centre, Mill 
Hill). Typically, 0.45 ml blood plasma or ultrafiltrate was 
placed in a 5 mm tube and 0.05 ml D20 added; either added 
TSP (sodium 3-trimethy1[2,2,3,3-‘Hhlpropionate), or internal 
alanine (1.487 ppm) was used as a chemical shift reference. 
Single-pulse spectra are the result of 32 (plasma)-128 (pro- 
teins) 45” pulses separated by a T, relaxation delay of 
1.5-2.4 s. The probe temperature was 298 K. Water saturation 
was achieved either with continuous or gated (off during ac- 
quisition) secondary irradiation. Free induction decays (FIDs) 
were accumulated into 16384 computer points and an exponen- 
tial, line-broadening function of 0.8 Hz was applied. 
Hahn spin-echo spectra [ 151 were acquired using the sequence 
90-I-180-1-collect-FID, usually with t = 60 ms. The CPMG 
sequence 90-(tl-180-tl)n-FID [16] was used for TZ studies. TI 
values were measured with the inversion-recovery sequence 
180~t-90-FID [17]. 
Additions of sodium D- or DL-lactate, lactic acid methyl 
ester, sodium 3-D-hydroxybutyrate or 2-hydroxybutyrate, L- 
alanine (all purchased from Sigma), NHEl, and NaHC03 were 
made as microlitre aliquots of stock solutions in DzO. SDS was 
added as a solid. 
Human apotransferrin, iron-saturated transferrin and 
al-antitrypsin were purchased from Sigma and dissolved in 
DzO (-14 mg/ml). Very low density lipoprotein (VLDL) was 
the kind gift of Dr P. Turner (St Thomas’ Hospital). The pH 
meter reading in DzO is referred to as pH*. 
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2.3. Enzyme assay 
L-Lactate was determined using a ‘Sigma Diagnostics’ 
pyruvate/lactate assay kit (lactate dehydrogenase/NAD+). This 
was checked with 0.88 and 12.3 mM reference solutions of L- 
Lac and DL-Lac, respectively. 
3. RESULTS 
Typical 500 MHz ‘H NMR single-pulse and 
Hahn spin-echo spectra of heparinised human 
blood plasma are shown in fig.la and c, respective- 
ly. In spin-echo spectra of the corresponding 
ultrafiltrates (< IO kDa, not shown) there are large 
increases in the intensities of the lactate resonances 
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Fig. 1. 500 MHz ‘H NMR spectra of human blood plasma: (a,b) 
single-pulse spectra, and (c,d) Hahn spin-echo spectra, before 
and after addition of NHdCl (0.5 M), respectively. (e) Increase 
in height of the lactate CH3 spin-echo peak with increasing 
concentration of added NH4CI; for this experiment a separate 
sample containing added sodium DL-lactate (2 mM) was used. 
Assignments: Ala, alanine; Glc, glucose; Lac, lactate; NAc, N- 
acetyls of glycoproteins; NMe, choline head groups of HDL 
(and LDL for single-pulse); PlrP2, CH, of HDL and LDL, and 
chylomicrons and VLDL, respectively; P3, CHz of 
chylomicrons and VLDL; Val, valine. 
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(up to 200%) relative to those of alanine, or valine. 
Addition of certain agents to intact plasma 
dramatically increases the relative intensities of 
both the lactate CH3 (doublet, 1.33 ppm) and CH 
(quartet, 4.11 ppm) resonances. These include 
SDS (50-200 mM), NaCl (2 M), HC104, NH&I 
(fig.lb,d) as well as increases in temperature (to 
50°C). 
As shown in fig. le, the lactate CHJ peak intensi- 
ty increases almost linearly with added NH4Cl con- 
centration, plateauing at about 0.5 M. Typically, 
after addition of NH&l (0.5 M), lactate CH3 
linewidths decrease from -3.5 to 2.2 Hz, whilst 
those for alanine remain unchanged (2.3 Hz). It is 
possible that all the lactate contributes to the 
single-pulse spectrum; however, although an 
allowance can be made for the overlapping 
threonine peak, integration is hampered by the 
large lipid CH2 signal, hence the need to use spin- 
echo spectra. 
Only after addition of NH4Cl is it possible to 
make a reliable estimation of the total lactate con- 
centration in plasma from the spin-echo spectrum. 
For 3 typical plasma samples, the concentrations 
of lactate determined from spin-echo peak heights, 
calibrated via standard additions of alanine were 
1.10, 1.20 and 0.80 mM, about one-third of those 
obtained by enzyme assay (2.90, 3.50 and 
2.45 mM, respectively). The NMR determinations 
on intact plasma approached the latter values after 
addition of NH&l (0.5 M, 2.30, 3.00 and 
1.80 mM) or SDS (200 mM, 2.50, 2.90 and 
2.00 mM), but those from NMR spectra of plasma 
ultrafiltrates were closer: 2.80, 3.20 and 2.30 mM. 
SDS and NH&l had no effect on the relative inten- 
sities of signals in the spectra of ultrafiltrates. 
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Fig.2. 500 MHz ‘H NMR spectra of the high-molecular-mass (> 10 kDa) fraction of human blood plsma. (i) Single-pulse spectra, (ii) 
Hahn spin-echo spectra. (a) No addition, (b) addition of alanine and lactate (0.25 mM each), (c) addition of Tris-DCI buffer to raise 
the pH* from 5.5 to 7.4, (d) addition of NHXI (0.5 M). Assignments as in fig.1, also T, Tris; A, acetone (tube contaminant); B, 
unassigned; x, spinning side-bands. 
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Experiments were carried out to investigate the 
origin of the effects on lactate resonances. Spectra 
acquired without Hz0 suppression from a freeze- 
dried sample of plasma redissolved in D20 showed 
similar increases in the intensities of lactate on ad- 
dition of NHdCl. This suggested that cross- 
saturation and spin-diffusion effects arising from 
Hz0 irradiation were not involved. The relaxation 
delay was varied from 2 to 10 s with little change 
in spectra, appearing to rule out rr effects. The 
behaviour of lactate peaks was similar in both 
Hahn and CPMG spectra, eliminating molecular 
diffusion as a cause, and was not dependent on the 
type of anticoagulant (EDTA, heparin or citrate). 
As judged from CPMG spectra (2nt = 
20-180 ms), there appeared to be little difference 
between the decay of the slowly relaxing com- 
ponents of the transverse magnetization of the 
CH3 groups of lactate and alanine, either before or 
after addition of NH&I. It seems likely that there 
is also a fast-relaxing component for lactate. 
However, the interpretation of these data is com- 
plicated by the problems of spectral overlap and 
spin-spin couplings [ 181. 
Dramatic attenuations of peak intensities were 
observed when lactate was added to the high- 
molecular-mass (> 10 kDa) fraction of plasma. 
Equimolar standard solutions of lactate and 
alanine were added to plasma dialysed vs H20. 
Alanine CH3 and CH resonances are well-resolved 
and increase linearly in intensity with added stan- 
dard (0.5-1.6 mM), but no peaks for lactate are 
visible in either single-pulse or Hahn spin-echo 
spectra (fig.2(i)a,b,(ii)a,b). When the pH* was 
raised from 5.5 (isoionic point) to 7.4 with Tris- 
DC1 buffer, a small shoulder for the lactate CH3 
appeared in the single-pulse spectrum (fig.2(i)c) 
and a small inverted doublet in the spin-echo spec- 
trum (fig.2(ii)c). Only after addition of NH&l did 
the intensity of lactate resonances reach those of 
Ala (fig.2(i)d,(ii)d). The increase in intensity of the 
lactate doublet beyond that of alanine suggests 
that even extensive dialysis did not remove all the 
lactate in this sample, and that some is tightly 
bound. When 0.15 M NaCl was used in the 
dialysis, similar results were obtained. 
The possible involvement of specific plasma pro- 
teins in lactate interactions was investigated. As 
shown in fig.3, commercial samples of human 
diferric transferrin contain NMR-invisible lactate 
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Fig.3. 500 MHz ‘H NMR spectra of human iron-saturated 
transferrin. (a) DzO, pH* 5.5; (b) after addition of NaHC03 
(15 mM) and 95% 02/5% COz, pH* 7.5. Assignments: Lac, 
lactate; AC, acetate; NAc, N-acetyls of carbohydrate side 
chains. Insets: portions of the corresponding Hahn spin-echo 
spectra. 
which appears after addition of competing anions 
such as bicarbonate. Apotransferrin [19] and 
al-antitrypsin behave similarly. On the other hand, 
isolated VLDL had no effect on lactate peaks. 
Similar effects were found for some other 
physiologically important carboxylic acids. Thus, 
although the intensities of the peaks for lactate 
methyl ester added to plasma were not affected by 
NH&l addition, those for 3-D-hydroxybutyrate, 
acetoacetate (ketone bodies), and 2-hydroxy- 
butyrate did increase in intensity (> 100%) relative 
to those of alanine, valine, glucose, and N-acetyls 
of glycoproteins. Such effects were also observed 
with plasma from ketoacidotic diabetic subjects. 
4. DISCUSSION 
The detection and quantitation of lactate and 
other small organic molecules in blood plasma, 
plasma fractions and other biological materials is 
a subject of much current interest. The work 
reported here has clearly shown that specific 
broadening of lactate resonances can occur in nor- 
mal single-pulse spectra of plasma such that the in- 
tensities of spin-echo resonances are severely 
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attenuated. Under some conditions, lactate added 
to the high-molecular-mass (> 10 kDa) fraction of 
plasma gives resonances which are too broad to 
detect in either spin-echo or normal spectra. 
In a previous paper [2], we noted that although 
NMR assays for alanine and valine in intact 
plasma were in reasonable agreement with conven- 
tional assays, there were discrepancies between 
NMR and enzyme assays of lactate. The data 
reported here provide insight into the reasons for 
these discrepancies. Recently, Grasdalen et al. [ 111 
measured, by spin-echo NMR, the concentrations 
of small molecules in plasma of subjects with 
chronic renal failure during haemodialysis. It was 
notable that they had to use a correction factor of 
6.1 to convert lactate peak intensities to concentra- 
tions compared to a value of 1.1 for alanine. Again 
the present data suggest why this is so. Unfor- 
tunately, until the molecular basis of lactate in- 
teractions is understood, it cannot be assumed that 
the same correction factor will apply to all 
samples. 
Ohsaka et al. [6] have reported that lactate con- 
centrations in serum are easily determined by 
NMR from single-pulse spectra and can be used 
for cancer diagnosis. Their comments can only be 
said to refer to ‘NMR-visible’ lactate. We have 
found that NMR-visible lactate levels sometimes 
do provide useful information, particularly where 
comparisons are required within a similar set of 
samples, for example in maternal plasma they cor- 
relate with the length of the second stage of labour 
PO1 * 
Our findings also complicate the attempts by 
Mountford et al. [7] to link resonances with long 
‘Tz' values and chemical shifts similar to lactate in 
‘H NMR spectra of plasma and serum with cancer- 
associated lipoproteins. The interpretation of this 
region of the spectrum either in single-pulse or 
spin-echo spectra can now no longer be regarded as 
straightforward. Broadened lactate CH3 peaks 
could also contribute to the lipoprotein CH2 
linewidth which has been used in correlations with 
malignant cancer by Fossel et al. [S]. However, this 
test for cancer is of little general use in view of the 
complexities of the lipoprotein resonances 
themselves [4,21,22]. 
Although there are now many reports of the 
detection of lactate in vivo by ‘H NMR (e.g. 
[23-25]), few have examined the quantification 
problem. Because of the need to suppress the in- 
tense Hz0 signal and to simplify the spectra, spin- 
echo pulse sequences are used. Recent 
measurements by Chang et al. [14] have shown 
that only 25% of the lactate present in hypoxic or 
ischaemic rat brains appears to be observable by 
NMR. 
In our studies, the suppression of lactate signals 
may arise from binding to plasma proteins. The 
negatively charged detergent SDS, which is known 
to interact strongly with proteins [26], decreased 
lactate binding. NH: may cause local changes in 
protein structure through hydrogen-bonding in- 
teractions, although the Cl- added may also play 
a role in competing with lactate. An awareness of 
these effects is important if NHdCl is used as a 
relaxation agent for Hz0 suppression [27]. 
Further studies will be required to establish 
whether interactions with specific plasma proteins 
are sufficient to account for the effects on lactate 
resonances. We investigated transferrin initially 
because it is known to possess carboxylate-anion- 
binding sites [28]. Our finding that both apo- and 
diferric transferrin can contain NMR-invisible lac- 
tate was unexpected. Other ‘acute-phase’ 
glycoproteins present in higher concentrations may 
also bind lactate. We have found that 
cur-antitrypsin can cause severe broadening of lac- 
tate peaks under certain conditions. The factors 
which influence the rates of lactate exchange pro- 
cesses on the NMR time scale are not yet clear. 
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